Influence of pH on heat-induced aggregation and degradation of therapeutic monoclonal antibodies.

Monoclonal antibodies are widely used for the treatment of various diseases, and because therapeutic monoclonal antibodies are stored in an aqueous solution or in a lyophilized state, the preparation of a stabilizing formulation that prevents their deterioration (degradation and aggregation) is crucial. Given the structural similarities of the immunoglobulin G (IgG) framework regions and a diversity of only four subclasses, we aimed to find common conditions that stabilize many different antibodies. In this study, we analyzed the effect of pH (the most critical factor in establishing a stable formulation) on human monoclonal antibodies from subclasses IgG1, IgG2, and IgG4, all of which have been utilized in antibody therapeutics. We found that human IgGs are stable with minimal heat-induced degradation and aggregation at pH 5.0-5.5 irrespective of their subclass. We also found that IgG1 is more susceptible to fragmentation, whereas IgG4 is more susceptible to aggregation. This basic information emphasizing the influence of pH on IgG stability should facilitate the optimization of formulation conditions tailored to individual antibodies for specific uses.

[1]  E. Ward,et al.  Evidence that the hinge region plays a role in maintaining serum levels of the murine IgG1 molecule. , 1995, Molecular immunology.

[2]  R. Aalberse,et al.  IgG4 breaking the rules , 2002, Immunology.

[3]  D. Davies,et al.  Structural basis of antibody function. , 1983, Annual review of immunology.

[4]  John F. Carpenter,et al.  Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation , 2003, Pharmaceutical Research.

[5]  I. Shimada,et al.  Carbon-13 NMR study of switch variant anti-dansyl antibodies: antigen binding and domain-domain interactions. , 1991, Biochemistry.

[6]  C. N. Gamble.  The role of soluble aggregates in the primary immune response of mice to human gamma globulin. , 1966, International archives of allergy and applied immunology.

[7]  R. Borchardt,et al.  Chemical Pathways of Peptide Degradation. I. Deamidation of Adrenocorticotropic Hormone , 1990, Pharmaceutical Research.

[8]  Wei Wang,et al.  Protein aggregation and its inhibition in biopharmaceutics. , 2005, International journal of pharmaceutics.

[9]  A R Rees,et al.  Humanization of murine monoclonal antibodies through variable domain resurfacing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Demarest,et al.  A broad range of Fab stabilities within a host of therapeutic IgGs. , 2007, Biochemical and biophysical research communications.

[11]  R Tyler-Cross,et al.  Effects of amino acid sequence, buffers, and ionic strength on the rate and mechanism of deamidation of asparagine residues in small peptides. , 1991, The Journal of biological chemistry.

[12]  M Goodall,et al.  The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. , 2000, Molecular immunology.

[13]  R. Ghirlando,et al.  Glycosylation of human IgG-Fc: influences on structure revealed by differential scanning micro-calorimetry. , 1999, Immunology letters.

[14]  L. Matsuuchi,et al.  Structure and function of the B-cell antigen receptor. , 1994, Chemical immunology.

[15]  A. Rosenberg,et al.  Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.

[16]  A. Sarai,et al.  Comparative thermodynamic analyses of the Fv, Fab* and Fab and Fab fragments of anti‐dansyl mouse monoclonal antibody , 1995 .

[17]  V. Zav'yalov,et al.  Mechanisms of Generation of Antibody Diversity as a Cause for Natural Selection of Homoiothermal Animals in the Process of Evolution , 1991, Scandinavian journal of immunology.

[18]  Allen Schantz,et al.  Immunogenicity of therapeutic monoclonal antibodies. , 2003, Current opinion in molecular therapeutics.

[19]  Huub Schellekens,et al.  Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation. , 2006, Journal of Pharmacy and Science.

[20]  Colleen E. Price,et al.  Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.

[21]  Shahid Uddin,et al.  Factors influencing antibody stability at solid–liquid interfaces in a high shear environment , 2009, Biotechnology progress.

[22]  A. Vermeer,et al.  Adsorption of IgG onto hydrophobic teflon. Differences between the F(ab) and F(c) domains. , 2001, Biochimica et biophysica acta.

[23]  Eiji Sawa,et al.  Prevention of stirring-induced microparticle formation in monoclonal antibody solutions. , 2010, Biological & pharmaceutical bulletin.